Five-year follow-up from the small, randomized REVELATION trial indicates that rates of clinical events are similar between STEMI patients initially randomized to a drug-coated balloon (DCB) or ...
WASHINGTON, DC—A newly approved drug-coated balloon (DCB) for the treatment of in-stent restenosis (ISR) continues to be safe and effective, with fewer events and repeat interventions compared with ...
Please provide your email address to receive an email when new articles are posted on . A novel low-dose paclitaxel-coated balloon was noninferior to a higher-dose paclitaxel-coated balloon at 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results